SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
郭政飞
Lv2
170 积分
2023-06-01 加入
最近求助
最近应助
互助留言
Exploring the next generation of antibody–drug conjugates
1天前
已完结
The antibody-drug conjugate landscape
1天前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
10天前
已完结
Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice
10天前
已完结
Targeting CDK6 in hormone receptor-positive breast cancer: inhibitor discovery for precision oncology through dynamics study
11天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
2个月前
已完结
Targeting CDK4 and CDK6 in cancer
2个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
4个月前
已完结
AXL activates YAP through the EGFR–LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma
5个月前
已完结
H 2 ‐Directing Strategy on In Situ Synthesis of Co‐MoS 2 with Highly Expanded Interlayer for Elegant HER Activity and its Mechanism
11个月前
已驳回
感谢
1天前
感谢,点赞
1天前
感谢,点赞,速度真快
8天前
点赞
10天前
感谢
10天前
速度真快
4个月前
点赞
5个月前
感谢
6个月前
感谢
8个月前
点赞
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论